Jesús Calviño

744 total citations
24 papers, 529 citations indexed

About

Jesús Calviño is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Jesús Calviño has authored 24 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Jesús Calviño's work include Renal Transplantation Outcomes and Treatments (3 papers), Restless Legs Syndrome Research (3 papers) and Dialysis and Renal Disease Management (3 papers). Jesús Calviño is often cited by papers focused on Renal Transplantation Outcomes and Treatments (3 papers), Restless Legs Syndrome Research (3 papers) and Dialysis and Renal Disease Management (3 papers). Jesús Calviño collaborates with scholars based in Spain, United States and Sweden. Jesús Calviño's co-authors include María M. Adeva, Cristóbal Donapetry, Gema Souto, Xosé M. Lens, Rafael Romero, Rafael Romero, E. Pintos, Secundino Cigarrán, R. Romero and Beatriz San Millán and has published in prestigious journals such as PLoS ONE, American Journal of Kidney Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Jesús Calviño

23 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Calviño Spain 12 127 121 118 115 91 24 529
Magdalena Jankowska Poland 14 49 0.4× 76 0.6× 90 0.8× 217 1.9× 73 0.8× 60 559
Katarzyna Taranta‐Janusz Poland 14 132 1.0× 87 0.7× 183 1.6× 241 2.1× 87 1.0× 53 756
Marinus H. de Keijzer Netherlands 13 90 0.7× 38 0.3× 62 0.5× 118 1.0× 229 2.5× 35 598
Bruna Bellincanta Nicoletto Brazil 10 40 0.3× 51 0.4× 92 0.8× 54 0.5× 134 1.5× 26 379
Miguel Ayala León Chile 10 95 0.7× 181 1.5× 150 1.3× 363 3.2× 190 2.1× 16 821
Xuesen Cao China 15 120 0.9× 64 0.5× 82 0.7× 299 2.6× 100 1.1× 55 656
P. Evenepoel Belgium 11 183 1.4× 30 0.2× 145 1.2× 466 4.1× 133 1.5× 12 787
Alexandros Rovas Germany 13 68 0.5× 289 2.4× 52 0.4× 83 0.7× 147 1.6× 26 845
Vinícius Daher Alvares Delfino Brazil 12 39 0.3× 61 0.5× 67 0.6× 107 0.9× 131 1.4× 56 487
Olaf Heisel Canada 6 37 0.3× 74 0.6× 72 0.6× 54 0.5× 249 2.7× 11 583

Countries citing papers authored by Jesús Calviño

Since Specialization
Citations

This map shows the geographic impact of Jesús Calviño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Calviño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Calviño more than expected).

Fields of papers citing papers by Jesús Calviño

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Calviño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Calviño. The network helps show where Jesús Calviño may publish in the future.

Co-authorship network of co-authors of Jesús Calviño

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Calviño. A scholar is included among the top collaborators of Jesús Calviño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Calviño. Jesús Calviño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sánchez‐Fructuoso, Ana, Juan Carlos Ruiz, Antonio Franco, et al.. (2019). Effectiveness and safety of the conversion to MeltDose® extended‐release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study. Clinical Transplantation. 34(1). e13767–e13767. 15 indexed citations
2.
Calviño, Jesús, et al.. (2018). Restless Legs Syndrome: An Unresolved Uremic Disorder after Renal Transplantation. ˜The œNephron journals/Nephron journals. 139(1). 23–29. 7 indexed citations
3.
Calviño, Jesús, et al.. (2018). Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant. PLoS ONE. 13(8). e0201118–e0201118. 18 indexed citations
4.
Millán, Beatriz San, et al.. (2017). Libman-Sacks’ endocarditis: A frequently unnoticed complication. Nefrología (English Edition). 37(2). 217–219. 2 indexed citations
5.
Cigarrán, Secundino, et al.. (2017). Déficit de testosterona en los pacientes en diálisis: diferencias según la técnica de diálisis. Nefrología. 37(5). 526–530. 8 indexed citations
6.
Cigarrán, Secundino, et al.. (2017). Testosterone deficiency in dialysis patients: Differences according to the dialysis techniques. Nefrología (English Edition). 37(5). 526–530. 3 indexed citations
7.
Calviño, Jesús, et al.. (2015). Restless Legs Syndrome in Non-Dialysis Renal Patients: Is It Really That Common?. Journal of Clinical Sleep Medicine. 11(1). 57–60. 15 indexed citations
8.
Calviño, Jesús, et al.. (2013). Flank Pain and Acute Renal Failure after Binge Drinking:A Growing Concern?. Renal Failure. 35(3). 421–424. 2 indexed citations
9.
Calviño, Jesús, María M. Adeva, & M.J. Sobrido. (2012). Membranous nephropathy, leiomyoma and autoimmune myasthenia: more than a coincidence?. Clinical Kidney Journal. 5(6). 562–565. 3 indexed citations
10.
Souto, Gema, Cristóbal Donapetry, Jesús Calviño, & María M. Adeva. (2011). Metabolic Acidosis-Induced Insulin Resistance and Cardiovascular Risk. Metabolic Syndrome and Related Disorders. 9(4). 247–253. 93 indexed citations
11.
Adeva, María M., Jesús Calviño, Gema Souto, & Cristóbal Donapetry. (2011). Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids. 43(1). 171–181. 137 indexed citations
12.
Molina, Esther, J.F. Castroagudı́n, Antonio Aguilera, et al.. (2010). Viral and host factors related with histopathologyc activity in patients with chronic hepatitis B and moderate or intermittently elevated alanine aminotransferase levels. Revista Española de Enfermedades Digestivas. 102(9). 519–25. 2 indexed citations
13.
Molina, Esther, J.F. Castroagudı́n, Jesús Calviño, et al.. (2009). Valganciclovir-Induced Leukopenia in Liver Transplant Recipients: Influence of Concomitant Use of Mycophenolate Mofetil. Transplantation Proceedings. 41(3). 1047–1049. 15 indexed citations
14.
Pérez, Evaristo Varo, et al.. (2002). Implantación ureteral en peritoneo. una complicación excepcional en el trasplante renal. Actas Urológicas Españolas. 26(8). 579–580. 1 indexed citations
15.
Romero, Rafael, et al.. (2000). Short‐term effect of atorvastatin in hypercholesterolaemic renal‐transplant patients unresponsive to other statins. Nephrology Dialysis Transplantation. 15(9). 1446–1449. 14 indexed citations
16.
Calviño, Jesús, et al.. (2000). Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension. Nephrology Dialysis Transplantation. 15(1). 82–86. 56 indexed citations
17.
Calviño, Jesús, et al.. (1999). Renal artery rupture secondary to pretransplantation Candida contamination of the graft in two different recipients. American Journal of Kidney Diseases. 33(1). E1–E5. 35 indexed citations
18.
Calviño, Jesús, et al.. (1999). Atherosclerosis profile and microalbuminuria in essential hypertension. American Journal of Kidney Diseases. 34(6). 996–1001. 26 indexed citations
19.
Calviño, Jesús, et al.. (1999). Secondary hyperparathyroidism exacerbation: a rare side-effect of interferon-alpha?. PubMed. 51(4). 248–51. 4 indexed citations
20.
Calviño, Jesús, et al.. (1998). Voluntary Ingestion of <i>Cortinarius</i> Mushrooms Leading to Chronic Interstitial Nephritis. American Journal of Nephrology. 18(6). 565–569. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026